Thromb Haemost 1984; 51(02): 212-216
DOI: 10.1055/s-0038-1661061
Original Article
Schattauer GmbH Stuttgart

Identification of Subpopulations of Human Urinary Plasminogen Activators

David A Hart
The Departments of Microbiology and Pediatrics, University of Texas Health Center at Dallas, Dallas, Texas, U.S.A.
,
Robert Kramer
The Departments of Microbiology and Pediatrics, University of Texas Health Center at Dallas, Dallas, Texas, U.S.A.
,
Witold Cieplak
The Departments of Microbiology and Pediatrics, University of Texas Health Center at Dallas, Dallas, Texas, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 08 August 1983

Accepted 30 January 1984

Publication Date:
19 July 2018 (online)

Summary

Enzymes functioning as plasminogen activators in commercial urokinase preparations and individual human urine concentrates were subjected to affinity chromatography on columns of lentil lectin-sepharose, ricin-sepharose, wheat germ agglutinin-sephar-ose, lotus lectin-sepharose and concanavalin A-sepharose.

Chromatography of the enzymes from both sources yielded similar results for all lectins except lentil lectin. Urokinase from several commercial sources was approximately 50% adherent to lentil lectin-sepharose while only 5-10% of the urinary plasminogen activators from individuals was adherent to this lectin. SDS-PAGE followed by zymography indicated that the observed differences between commercial and individual samples could be due to the presence in urine concentrates of subpopulations of plasminogen activators which were absent from the commercial samples.

 
  • References

  • 1 Barrett A. (ed) Proteinases in Mammalian Cells and Tissues. North-Holland Publishing Co.; Amsterdam: 1978
  • 2 Astrup T. Fibrinolysis: An overview. In: Progress in Chemical Fibrinolysis and Thrombolysis. Davidson JF, Rowan RM, Samama M, Desnoyers PC. (eds) Raven Press; New York: 1978. pp 1-57
  • 3 Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89
  • 4 Ogawa N, Yamamoto H, Katamine T, Tajima H. Purification and some properties of urokinase. Thrombos Diathes Haemorrh 1975; 34: 194-209
  • 5 Huber K, Kircheimer J, Binder B. Rapid isolation of high molecular weight urokinase from native human urine. Thromb Haemostas 1982; 47: 197-202
  • 6 Nobuhara M, Sakamaki M, Ohnishi H, Suzuki Y. A comparative study of high molecular weight urokinase and low molecular weight urokinase. J Biochem 1981; 90: 225-232
  • 7 Kaltoft K, Nielson L, Zuethen J, Dano K. Monoclonal antibody that specifically binds a 52,000-Mr plasminogen activating enzyme. Proc Natl Acad Sci USA 1982; 79: 3720-3723
  • 8 Vetterlein D, Bell T, Young P, Robbins R. Immunological characterization of multiple molecular weight forms of human cell plasminogen activators. J Biol Chem 1979; 255: 2665-2672
  • 9 Schaller J, Nick H, Rickli E, Gillessen D, Lergier W, Studer R. Human flow-molecular weight urinary urokinase: Partial characterization and preliminary sequence data of the two polypeptide chains. Eur J Biochem 1982; 125: 251-257
  • 10 Steffens G, Gunzler W, Otting F, Frankus E, Flohe L. The complete amino acid sequence of low molecular mass urokinase from human urine. Hoppe-Seyler’s Z Physiol Chem 1982; 363: 1043-1058
  • 11 Hung P. Biological activity of a cloned human enzyme urokinase. In: From Gene to Protein: Translation into Biotechnology. Ahmad F, Schultz J, Smith E, Whelan W. (eds) Academic Press; New York: 1982. pp 429-444
  • 12 Fulton RJ, Hart DA. Characterization of a plasma membrane- associated plasminogen activator on thymocytes. Biochim Biophys Acta 1981; 642: 345-364
  • 13 Cieplak W, Hart DA. Cell-associated plasminogen activator on rat and hamster peritoneal exudate cells. Fed Proc 1981; 41: 367
  • 14 Hart DA, Hendrix C, Fulton RJ, Cieplak W. Detection and partial characterization of proteases expressed by bone marrow cells. (Submitted for publication)
  • 15 Sueishi K, Nanno S, Okamura T, Ionuc S, Tanaka K. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase. Biochim Biophys Acta 1982; 717: 327-336
  • 16 Rijken D, Collen D. Purification and characterization of the plasminogen activators secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-7041
  • 17 Hart DA. Lectins in biological systems: applications to microbiology. Am J Clin Nutr 1980; 33: 2416-2425
  • 18 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 1970; 227: 680-682
  • 19 Granelli-Piperno A, Reich E. A study of proteases and protease inhibitor complexes in biological fluids. J Exp Med 1978; 148: 223-234
  • 20 Alhadeff JA. Glycoproteins and cystic fibrosis: a review. Clin Genetics 1978; 14: 189-201
  • 21 Ben-Joseph Y, Defranco CL, Nadler HL. Decreased sialic acid and altered binding to lectins of purified 2-macroglobulin from patients with cystic fibrosis. Clin Chim Acta 1979; 99: 31-35
  • 23 Schneider Ph, Bachmann F, Sauser D. Urokinase: A short review of its properties and of its metabolism. In: Urokinase: Basic and Clinical Applications. Mannucci PM, D’Angelo A. (eds) Academic Press; New York: 1982. pp 1-15
  • 24 Holmberg L, Astedt B. Radioimmunoassays of high and low molecular weight urokinase. In: Urokinase: Basic and Clinical Applications. Mannucci PM, D’Angelo A. (eds) Academic Press; New York: 1982. pp 33-42
  • 25 Kornfeld K, Reitman M, Kornfeld R. The carbohydrate-binding specificity of pea and lentil lectin. Fucose is an important determinant J Biol Chem 1981; 255: 6633-6640